Follow us on Facebook

One on One Support

Health Concerns
VA Issues  

Notice: Website under construction,

May 2014 VA Hep C Treatment Guidelines
UPDATE: Feb 26, 2016-
Funding and Prioritization Status Update

UPDATE: March 2016
VA Hep C Treatment Guidelines
VA to treat all vets in system

By Judith Graham
VA Extends New Hepatitis C Drugs to All Veterans in Its Health System

Orange Count Registry
Vietnam vets blame 'jet guns' for their hepatitis C
By Lily Leung Feb. 14, 2016 
CBS News Investigates
Congress outraged over hepatitis C treatment VA can't afford
Dr. Raymond Schinazi played a leading role developing a drug that cures hepatitis C while working seven-eighths of his time for the VA| By amynordrum

Hepatitis C drug costing VA, DoD millions
By Patricia Kime, Staff writer
We're looking at a company who is milking a cash cow for everything it's worth," Sanders said. 

VA to outsource care for 180,000 vets with hepatitis C
Dennis Wagner, The Arizona Republic 12:27 a.m. EDT June 21, 2015

VA to outsource care for 180,000 vets with hepatitis C
, The Republic | 11:51 a.m. MST June 19, 2015
Dr. David Ross, the VA's director public-health pathogens programs, resigned from the working group. "I cannot in good conscience continue to work on a plan for rationing care to veterans," he wrote.

VA Region Stops Referring Patients To Outside Hospitals Thanks To Budget Shortfall
Michael Volpe Contributor ...According to a memo — the entire region has been forced to stop all “non-VA care” referrals due to a budget shortfall.
Sen. Mark Kirk admitted the VA Choice Program is a failed joke in a letter to Secretary Bob McDonald despite attempts to fix it.

Denied Hep C VA dental care?
Please click here

Dried Hepatitis C Blood Exposure 11/23/2013 Weeks later inconspicuous blood transmits virus and more likely to cause accidental exposures to Hep C

Lack of Standards for
Mass Vaccinations
1970 Jetgun Nursing Instructions

2014 AASLD Study Hepatitis C not an STD

Test the Rest Campaign
Documentation & Surveillance Alerts
Military Hepatitis History  
Understanding The Liver 
VA Flow Sheet for Cirrhosis
VA Defines Risk Factors
Hep C & Pro-Prebiotic
Need to know-Grassroots Research
Blog Another12Weeks
One Vets' Journey Though Treatment

 Ask NOD
 What Would Veterans Do?
Blog for VA Claims

Help with VA Claims

Info: Plan Backfires-
VBA Fast Letter Boost Claims
Legal- Fed Regs state:
Judge decision may be relied upon
Cotant v. Principi, 17 Vet.App. 116, 134 (2003),
Service Connected Claims
# 1 Conclusion of Law 
# 2 Conclusion of Law 
More Claims
Jetgun Decisions
Hep C Decisions
Search Board of Appeals Website
BVA Jetgun Decisions
BVA Hepatitis C Decisions

Great Advice!  
After the jetgun win
What to do next



State of the world's vaccines and immunization programs

"However, tests have shown that the existing models already in use are not risk-free. Although no needle is used, some children have been found to bleed raising the spectre of cross-infection unless the metal cap is sterilized or changed before any subsequent immunizations. When tested on animal models the metal cap was found to be contaminated after 1 in 7 injections..."

World Health Organization * United Nations Children's Fund
Geneva 1996


Safe injections initiative
Almost a billion injections are given to women and children each year through national immunization programmes in developing countries. In 1994, WHO reported that surveys carried out in four of its six regions indicated that up to a third of immunization injections were unsterile and therefore unsafe.

But immunization injections account for less than 10% of injections administered within the health sector. And medical injections have an even worse safety record. More than half of all non-immunization injections in developing countries are believed to be unsafe. 

Up to a third of immunization Surveys carried out for WHO and UNICEF  a disturbing pattern of unsafe injection practices that can put the lives  of both children and health workers at risk. Contaminated needles and syringes are sometimes reused putting children at risk of cross  infection with blood-borne diseases such as hepatitis B and HIV. In one health centre in Romania health workers were found to be packaging used disposable syringes for resale using a hot iron to reseal the packaging. Elsewhere, reusable plastic syringes are inadequately sterilized and injections are sometimes wrongly administered resulting in injection-site abscesses. Improper disposal of contaminated needles and syringes is another problem placing the wider community at risk. Meanwhile, the incidence of accidental needlestick injury to health workers is alarmingly high an estimated 5 needlestick accidents for every 100 injections.

A survey carried out for UNICEF in Eastern Europe in 1992-93 revealed that almost 50% of health centres were giving unsafe injections and/or using vaccine of doubtful potency. In 13% of health centres there were no disposable syringes and no sterilizing equipment either. The study also revealed that children especially orphans were being subjected to an excessive number of injections
in addition to immunization an average of 115 injections in all during their first year. One orphan had been given over 500 injections.

In 1994, a conference in Côte d Ivoire involving more than 50 African countries endorsed the so-called Yamoussoukro Declaration on the safety of injections. Under this declaration, immunization



Programme managers and workers pledge to ensure that every injection is sterile and the public pledge to demand the right of access to injections that are safe. The Declaration also sets a target of 95% safe injections by the year 1997.

UNICEF, which supplies injection equipment to many developing countries, now recommends the use of auto-destruct syringes instead of disposable, single-use syringes in order to avoid the hazards of unsafe injection practices. The advantage of these syringes is that they cannot be reused or recycled for sale. But they are more expensive than either disposable or reusable (sterilizable) syringes and once contaminated they still require safe disposal. Over the past 3-4 years, annual sales of auto-destruct syringes have increased more than tenfold from 5 million to 60 million today.

But by the year 2000 a new device the low workload jet injector  is expected to revolutionize the business of giving injections. Adapted from a more powerful model first developed for the mass immunization of military personnel during the Second World War and from a smaller device used by diabetics for the daily injection of insulin, this device can project high-speed 100 metres a second intramuscular injections, penetrating the skin without the use of needles.

High workload jet injectors are already used in some countries mainly when large numbers of people are immunized during outbreaks or in refugee camps. Low workload jet injectors could be marketed for about US$ 300, and used for about 20,000 injections without needing maintenance providing two years service in the average health centre. The device will be cheap, convenient, avoid the risks of needlestick injuries, and leave nothing behind for disposal. It also holds out the prospect of use with vaccines in powder form measles vaccine, for example which are currently at the research stage. It may also be used at a future date to deliver several vaccines at the same time by mounting multiple vaccine vials on the injector.

However, tests have shown that the existing models already in use are not risk-free. Although no needle is used, some children have been found to bleed raising the spectre of cross-infection unless the metal cap is sterilized or changed before any subsequent immunizations. When tested on animal models the metal cap was found to be contaminated after 1 in 7 injections.


Tests are now being carried out by WHO in collaboration with the US Centers for Disease Control and the UK Public Health Laboratory Service on both high workload and prototype low workload jet injectors in an effort to eliminate the risk of contamination. Two possible adaptations are the development of a disposable plastic head or a disposal sheath to ensure that the device remains sterile. Meanwhile, Phase I laboratory tests are already under way and limited field trials are scheduled to take place during 1996 and 1997 in Brazil and the Philippines.

WHO website